Chestnut Hill, MA, United States of America

Philip B Komarnitsky

This inventor holds 8 USPTO granted patents and 8 published patent applications and 4 EPO patents. Top assignees: Ziopharm Oncology, Inc., Solasia Pharma K.k., Abbvie Manufacturing Management Unlimited Company. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip B Komarnitsky. Retrieved from https://idiyas.com/inventor/philip-b-komarnitsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 8)

% Patents Active = 50.0

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Chestnut Hill, CT (US) (2020)
Chestnut Hill, MA (US) (2012 - 2022)

Company Filing History:

4 out of 12

Ziopharm Oncology, Inc.

Abbvie Manufacturing Management Unlimited Company

patent

Years Active: 2012-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12433951 - Methods of treatment of non-small-cell lung carcinoma using telisotuzumab vedotin (2025-10-07),

2. 11324714 - Organoarsenic compounds and methods for the treatment of cancer (2022-05-10),

3. 11324713 - Organoarsenic compounds and methods for the treatment of cancer (2022-05-10),

4. 10842769 - Organoarsenic compounds and methods for the treatment of cancer (2020-11-24),

5. 9340563 - Salts of isophosphoramide mustard and analogs thereof (2016-05-17),

6. 8796329 - Method for controlling angiogenesis in animals (2014-08-05),

7. 8604007 - Salts of isophosphoramide mustard and analogs thereof (2013-12-10),

8. 8252773 - Combination therapy with organic arsenicals (2012-08-28),

Title: The Innovations of Philip B. Komarnitsky

Introduction

Philip B. Komarnitsky is a notable inventor based in Chestnut Hill, MA, with a significant contribution to the field of oncology. He holds a total of 8 patents, showcasing his dedication to advancing cancer treatment methodologies. His work primarily focuses on innovative approaches to combat various forms of cancer, particularly non-small-cell lung carcinoma.

Latest Patents

Among his latest patents, one includes "Methods of treatment of non-small-cell lung carcinoma using telisotuzumab vedotin." This patent presents improved methods for treating NSCLC cancers using this specific compound. Another significant patent is titled "Organoarsenic compounds and methods for the treatment of cancer." This patent outlines a method for treating lymphomas, including non-Hodgkin's and Hodgkin's lymphoma, through the administration of organoarsenic compounds with specific structural formulas.

Career Highlights

Throughout his career, Philip has worked with prominent companies in the pharmaceutical industry, including Ziopharm Oncology, Inc. and Solasia Pharma K.K. His experience in these organizations has allowed him to contribute to groundbreaking research and development in cancer therapies.

Collaborations

Philip has collaborated with esteemed colleagues such as Barbara P. Wallner and Brian Schwartz, further enhancing the impact of his work in the field of oncology.

Conclusion

Philip B. Komarnitsky's innovative contributions to cancer treatment through his patents and collaborations highlight his significant role in advancing medical science. His work continues to inspire future developments in oncology.

Profile summary based on public USPTO records.